| Literature DB >> 31311986 |
Yoichiro Oda1, Yuri Uchiyama2,3, Ai Motomura1, Atsushi Fujita2, Yoshiteru Azuma2, Yutaka Harita4, Takeshi Mizuguchi2, Kumiko Yanagi5, Hiroko Ogata6, Kenichiro Hata6, Tadashi Kaname5, Yoichi Matsubara7, Keiko Wakui8, Naomichi Matsumoto9.
Abstract
Complex rearrangements of chromosomes 3 and 9 were found in a patient presenting with severe epilepsy, developmental delay, dysmorphic facial features, and skeletal abnormalities. Molecular cytogenetic analysis revealed 46,XX.ish der(9)(3qter→3q28::9p21.1→9p22.3::9p22.3→9qter)(RP11-368G14+,RP11-299O8-,RP11-905L2++,RP11-775E6++). Her dysmorphic features are consistent with 3q29 microduplication syndrome and inv dup del(9p). Trio-based WES of the patient revealed no pathogenic single nucleotide variants causing epilepsy, but confirmed a 3q28q29 duplication involving FGF12, which encodes fibroblast growth factor 12. FGF12 positively regulates the activity of voltage-gated sodium channels. Recently, only one recurrent gain-of-function variant [NM_021032.4:c.341G>A:p.(Arg114His)] in FGF12 was found in a total of 10 patients with severe early-onset epilepsy. We propose that the patient's entire FGF12 duplication may be analogous to the gain-of-function variant in FGF12 in the epileptic phenotype of this patient.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31311986 DOI: 10.1038/s10038-019-0641-1
Source DB: PubMed Journal: J Hum Genet ISSN: 1434-5161 Impact factor: 3.172